Cargando…
Nanotherapeutics to Modulate the Compromised Micro-Environment for Lung Cancers and Chronic Obstructive Pulmonary Disease
The use of nanomaterials to modulate the tumor microenvironment has great potential to advance outcomes in patients with lung cancer. Nanomaterials can be used to prolong the delivery time of therapeutics enabling their specific targeting to tumors while minimizing and potentially eliminating cytoto...
Autores principales: | Seshadri, Dhruv R., Ramamurthi, Anand |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054931/ https://www.ncbi.nlm.nih.gov/pubmed/30061830 http://dx.doi.org/10.3389/fphar.2018.00759 |
Ejemplares similares
-
MicroRNA Nanotherapeutics for Lung Targeting. Insights into Pulmonary Hypertension
por: Carregal-Romero, Susana, et al.
Publicado: (2020) -
Lipid-engineered nanotherapeutics for cancer management
por: Fernandez-Fernandez, Alicia, et al.
Publicado: (2023) -
Editorial: New Approaches in Toxicity Testing of Nanotherapeutics
por: Kalangi, Suresh K., et al.
Publicado: (2022) -
Nanotherapeutics Overcoming the Blood-Brain Barrier for Glioblastoma Treatment
por: Tang, Lin, et al.
Publicado: (2021) -
Role of Proteases in Chronic Obstructive Pulmonary Disease
por: Pandey, Kailash C., et al.
Publicado: (2017)